ANXIETY DISORDERS (or Anxiety and Phobic Neuroses)
7
2
2
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
Reward Processing and Exposure Therapy for Social Anxiety Disorder
Digital Interventions for Relapse Prevention in Adolescence
Internet-Delivered Cognitive Behavioral Intervention for Youths With Anxiety Disorders
Interactive E-Learning for Therapist Training in Exposure Therapy
Pediatric Behavioral Health Integrated Care: Indiana Statewide Strategic Plan to Address the Growing Mental Health Crisis
Is Betwixt App Effective and Acceptable?
Fast-Fail Trials in Mood and Anxiety Spectrum Disorders; Kappa Opioid Receptor Phase 2a